545 related articles for article (PubMed ID: 27609596)
1. Introduction of a PCT-based algorithm to guide antibiotic prescription in COPD exacerbation.
Picart J; Moiton MP; Gaüzère BA; Gazaille V; Combes X; DiBernardo S
Med Mal Infect; 2016 Dec; 46(8):429-435. PubMed ID: 27609596
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD.
Corti C; Fally M; Fabricius-Bjerre A; Mortensen K; Jensen BN; Andreassen HF; Porsbjerg C; Knudsen JD; Jensen JU
Int J Chron Obstruct Pulmon Dis; 2016; 11():1381-9. PubMed ID: 27382274
[TBL] [Abstract][Full Text] [Related]
3. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin Biomarker Algorithm Reduces Antibiotic Prescriptions, Duration of Therapy, and Costs in Chronic Obstructive Pulmonary Disease: A Comparison in the Netherlands, Germany, and the United Kingdom.
van der Maas ME; Mantjes G; Steuten LM
OMICS; 2017 Apr; 21(4):232-243. PubMed ID: 28388301
[TBL] [Abstract][Full Text] [Related]
5. An audit and feedback intervention study increased adherence to antibiotic prescribing guidelines at a Norwegian hospital.
Høgli JU; Garcia BH; Skjold F; Skogen V; Småbrekke L
BMC Infect Dis; 2016 Feb; 16():96. PubMed ID: 26920549
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
[TBL] [Abstract][Full Text] [Related]
7. Retrospective audit of antimicrobial prescribing practices for acute exacerbations of chronic obstructive pulmonary diseases in a large regional hospital.
Brownridge DJ; Zaidi STR
J Clin Pharm Ther; 2017 Jun; 42(3):301-305. PubMed ID: 28251670
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
[TBL] [Abstract][Full Text] [Related]
9. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation.
Lindenauer PK; Shieh MS; Stefan MS; Fisher KA; Haessler SD; Pekow PS; Rothberg MB; Krishnan JA; Walkey AJ
Ann Am Thorac Soc; 2017 Dec; 14(12):1779-1785. PubMed ID: 28795838
[TBL] [Abstract][Full Text] [Related]
10. Order Set to Improve the Care of Patients Hospitalized for an Exacerbation of Chronic Obstructive Pulmonary Disease.
Brown KE; Johnson KJ; DeRonne BM; Parenti CM; Rice KL
Ann Am Thorac Soc; 2016 Jun; 13(6):811-5. PubMed ID: 27058777
[TBL] [Abstract][Full Text] [Related]
11. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
[TBL] [Abstract][Full Text] [Related]
12. C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations.
Butler CC; Gillespie D; White P; Bates J; Lowe R; Thomas-Jones E; Wootton M; Hood K; Phillips R; Melbye H; Llor C; Cals JWL; Naik G; Kirby N; Gal M; Riga E; Francis NA
N Engl J Med; 2019 Jul; 381(2):111-120. PubMed ID: 31291514
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.
Taverner J; Ross L; Bartlett C; Luthe M; Ong J; Irving L; Smallwood N
Intern Med J; 2019 Jan; 49(1):66-73. PubMed ID: 29740931
[TBL] [Abstract][Full Text] [Related]
14. An investigation of the effects of procalcitonin testing on antimicrobial prescribing in respiratory tract infections in an Irish university hospital setting: a feasibility study.
O'Riordan F; Shiely F; Byrne S; O'Brien D; Palmer B; Dahly D; O'Connor TM; Curran D; Fleming A
J Antimicrob Chemother; 2019 Nov; 74(11):3352-3361. PubMed ID: 31325313
[TBL] [Abstract][Full Text] [Related]
15. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.
Schuetz P; Christ-Crain M; Thomann R; Falconnier C; Wolbers M; Widmer I; Neidert S; Fricker T; Blum C; Schild U; Regez K; Schoenenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Mueller B;
JAMA; 2009 Sep; 302(10):1059-66. PubMed ID: 19738090
[TBL] [Abstract][Full Text] [Related]
16. Potential of serum procalcitonin in predicting bacterial exacerbation and guiding antibiotic administration in severe COPD exacerbations: a systematic review and meta-analysis.
Ni W; Bao J; Yang D; Xi W; Wang K; Xu Y; Zhang R; Gao Z
Infect Dis (Lond); 2019 Sep; 51(9):639-650. PubMed ID: 31355690
[No Abstract] [Full Text] [Related]
17. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
[TBL] [Abstract][Full Text] [Related]
18. Opportunities to reduce antibiotic prescribing for patients with COPD in primary care: a cohort study using electronic health records from the Clinical Practice Research Datalink (CPRD).
Rockenschaub P; Jhass A; Freemantle N; Aryee A; Rafiq M; Hayward A; Shallcross L
J Antimicrob Chemother; 2020 Jan; 75(1):243-251. PubMed ID: 31598669
[TBL] [Abstract][Full Text] [Related]
19. An intervention with access to C-reactive protein rapid test reduces antibiotic overprescribing in acute exacerbations of chronic bronchitis and COPD.
Strykowski DF; Nielsen AB; Llor C; Siersma V; Bjerrum L
Fam Pract; 2015 Aug; 32(4):395-400. PubMed ID: 25902912
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of antibiotic use and impact of an intervention intended to modify the prescribing behavior in surgical prophylaxis in 6hospitals in the metropolitan area of Monterrey, Mexico].
Palacios-Saucedo GDC; de la Garza-Camargo M; Briones-Lara E; Carmona-González S; García-Cabello R; Islas-Esparza LA; Saldaña-Flores G; González-Cano JR; González-Ruvalcaba R; Valadez-Botello FJ; Muñoz-Maldonado GE; Montero-Cantú CA; Díaz-Ramos RD; Solórzano-Santos F
Cir Cir; 2017; 85(6):459-470. PubMed ID: 28063606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
